12:00 AM
 | 
Jan 28, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Kazano alogliptin/metformin regulatory update

FDA approved Kazano alogliptin/metformin from Takeda as an adjunct to diet and exercise to improve blood sugar control in adult Type II diabetics. The pharma plans to launch the product...

Read the full 130 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >